Henry Schein Exceeds Q1 Estimates, Maintains Annual Profit Outlook

• Adjusted earnings reached $1.32 per share in Q1, beating analyst estimates of $1.27, while revenue of $3.4 billion exceeded expectations of $3.34 billion
• The Global Distribution and Value-Added Services segment, the company's largest, grew 6.1% to $2.84 billion in revenue
• Company maintained its 2026 sales growth forecast of 3% to 5%, with analysts noting the stable outlook is unsurprising given current macroeconomic uncertainty

Henry Schein Q1 2025 Earnings Summary

Key Results:

Henry Schein exceeded Wall Street expectations for Q1, reporting adjusted earnings of $1.32 per share and revenue of $3.4 billion, representing 6.3% growth versus analyst estimates of $3.34 billion.

Financial Outlook:

The medical supplies distributor reaffirmed its full-year 2026 guidance, maintaining adjusted profit forecasts of $5.23 to $5.37 per share and expected sales growth of 3% to 5%. According to Leerink Partners analyst Michael Cherny, this confirmation is "unsurprising given a backdrop of macro uncertainty."

Segment Performance:

• Global Distribution and Value-Added Services (largest segment): Revenue grew 6.1% to $2.84 billion
• Global Specialty Products (dental implants and biomaterials): Revenue increased 8.1% to $397 million
• Global Technology (practice-management software and digital services): Sales rose 7% to $173 million

Market Context:

The U.S. dental market continues experiencing instability characterized by uneven patient visits and weakening demand for higher-cost procedures. Analysts expect market conditions to stabilize by 2026. Despite these headwinds, Henry Schein demonstrated strong momentum in its dental business segment, continuing positive trends from the second half of last year.

Investment Implications:

The company's ability to beat Q1 estimates while maintaining annual guidance amid dental market volatility signals operational resilience. Strong performance across all three business segments, particularly the 8.1% growth in specialty products, suggests successful market share gains despite macroeconomic uncertainty.